Other digital media

Dupixent® (dupilumab) Application for Treatment of Chronic Spontaneous Urticaria (CSU) in …

Chief Editor March 7, 2023 0 3 sec read

Dupixent® (dupilumab) Application for Treatment of Chronic Spontaneous Urticaria (CSU) in …

Source link

Chief Editor

Previous Article Aventis Groupe: Press Release: Dupixent® (dupilumab) application for treatment of chronic spontaneous urticaria (CSU) in adults and adolescents accepted for FDA review

Next Article According to CMi Global Industrial Electrification Market Size, Forecast, Analysis & Share Surpass US$ 129 Bn By 2030

IPI Nigeria Inaugurates Programmes, Advocacy, Funding C’ttees

The Nigerian national committee of the International Press Institute (IPI Nigeria) has inaugurated three standing committees to help drive the organisation’s objective of promoting journalism […]

April 13, 2023 0 37 sec read

DIRECTOR DEALINGS: Serco CEO sells 1.9 million shares; LBG CEO buys

(Alliance News) – The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by […]

November 9, 2022 0 35 sec read

Tata Capital unveils new campaign promoting its offerings

Mumbai: Tata Capital has unveiled its integrated marketing campaign “Palak jhapkao, loan paao!” to promote its various loan offerings. The campaign has a series of […]

November 11, 2022 0 35 sec read

Save the Date: Food Safety Consortium 2023 October 16-18

The Food Safety Consortium, now in its 11th year, will take place October 16-18, 2023, at the Hilton in Parsippany, New Jersey. Presented by Food […]

February 21, 2023 0 37 sec read

All Media Info